COVID-19 Rebound Cases Most Likely More Common Than Data Indicate, Experts Say

CNN (8/26, McPhillips) reported on the prevalence of COVID-19 rebound cases either independent of or associated with treatment, including with Pfizer’s antiviral nirmatrelvir/ritonavir (Paxlovid). A CDC spokesperson said, “From the data we have so far, CO...